February 17, 2023 - Researchers at Harvard T.H. Chan School of Public Health have developed a new, highly adaptable vaccine platform that could potentially be a powerful tool in the fight against viral pathogens including influenza, HIV, and SARS-CoV-2.Postdoctoral fellow Sengjin Choi; Quan Lu, Cecil K. and Philip Drinker Professor of Environmental Physiology; and others in Lu's lab created a platform that makes use of tiny particles found in the body called extracellular vesicles, or EVs, which transport various molecules among cells.
[
add
]
[
|
|
...
]